Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Launched by MICHIGAN STATE UNIVERSITY · Jul 17, 2013

Keywords

ClinConnect Summary

This clinical trial is studying a new technology designed to quickly and accurately identify the germs causing infections in patients who may be experiencing severe infections or sepsis, a serious condition where the body reacts strongly to infection. The researchers want to see if this new method can find the specific germs and their resistance to antibiotics faster than traditional lab tests. Patients who meet certain criteria, such as having signs of inflammation in their body (like a rapid heartbeat or fever) and who are having bodily fluids collected for testing, may be eligible to participate.

If you join the study, you will have your standard tests performed as usual for your care, and your samples will be analyzed later to compare the results from the new technology with the standard tests. Importantly, this trial will not change the way you receive treatment for your infection. The aim is to improve how infections are diagnosed in the future, which could lead to quicker and more effective treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients with 3 of 4 systemic inflammatory response syndrome (SIRS) characteristics (1. tachycardia, 2. fever or hypothermia, 3. tachypnea, 4. leukocytosis), who have blood cultures drawn and urine collected for the evaluation of suspected sepsis, and/or other bodily fluids collected for culture and sensitivity analysis.
• • Patients with other sources of infection with less than 3 of 4 SIRS criteria
• Exclusion Criteria:
• • Pediatric patients